Actinic Keratosis in Solid Organ Transplant Recipients : A Medical Literature Review
Copyright © 2023 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved..
Pharmacological immunosuppression in solid organ transplant recipients is a significant risk factor in the occurrence of actinic keratosis (AK) and later progression into squamous cell carcinomas (SCC). Treating clinical and preclinical lesions is mandatory in this group of patients due to the high changes of progression into SCC. On the other hand, prevention of AK should be considered because it plays a crucial role. Several studies have been published on immunocompetent patients, as well as on the management and prevention of AK, but not on immunosuppressed patients. This review aims to summarize the current knowledge on the management and prevention measures of AK in solid organ transplant recipients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:115 |
---|---|
Enthalten in: |
Actas dermo-sifiliograficas - 115(2024), 4 vom: 23. Apr., Seite 368-373 |
Sprache: |
Englisch |
---|
Weiterer Titel: |
Queratosis actínicas en pacientes trasplantados de órgano sólido: revisión de la literatura |
---|
Beteiligte Personen: |
Morelló Vicente, A [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 05.04.2024 Date Revised 05.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ad.2023.10.021 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364169206 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364169206 | ||
003 | DE-627 | ||
005 | 20240405233203.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ad.2023.10.021 |2 doi | |
028 | 5 | 2 | |a pubmed24n1366.xml |
035 | |a (DE-627)NLM364169206 | ||
035 | |a (NLM)37925069 | ||
035 | |a (PII)S0001-7310(23)00853-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Morelló Vicente, A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Actinic Keratosis in Solid Organ Transplant Recipients |b A Medical Literature Review |
246 | 3 | 3 | |a Queratosis actínicas en pacientes trasplantados de órgano sólido: revisión de la literatura |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.04.2024 | ||
500 | |a Date Revised 05.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved. | ||
520 | |a Pharmacological immunosuppression in solid organ transplant recipients is a significant risk factor in the occurrence of actinic keratosis (AK) and later progression into squamous cell carcinomas (SCC). Treating clinical and preclinical lesions is mandatory in this group of patients due to the high changes of progression into SCC. On the other hand, prevention of AK should be considered because it plays a crucial role. Several studies have been published on immunocompetent patients, as well as on the management and prevention of AK, but not on immunosuppressed patients. This review aims to summarize the current knowledge on the management and prevention measures of AK in solid organ transplant recipients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Actinic keratosis | |
650 | 4 | |a Carcinoma escamoso | |
650 | 4 | |a Immunosuppression | |
650 | 4 | |a Inmunosupresión | |
650 | 4 | |a Queratosis actínicas | |
650 | 4 | |a Solid organ transplant recipients | |
650 | 4 | |a Squamous cell carcinoma | |
650 | 4 | |a Trasplantados de órgano sólido | |
700 | 1 | |a Oteiza Rius, I |e verfasserin |4 aut | |
700 | 1 | |a Aguado Gil, L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Actas dermo-sifiliograficas |d 1945 |g 115(2024), 4 vom: 23. Apr., Seite 368-373 |w (DE-627)NLM000271438 |x 1578-2190 |7 nnns |
773 | 1 | 8 | |g volume:115 |g year:2024 |g number:4 |g day:23 |g month:04 |g pages:368-373 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ad.2023.10.021 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 115 |j 2024 |e 4 |b 23 |c 04 |h 368-373 |